Gong Chunmei, Setzen Raymond, Liu Zhongqiong, Liu Yunchang, Xie Bin, Aili Aixingzi, Zhang Lian
State Key Laboratory of Ultrasound Engineering in Medicine Co-founded by Chongqing and the Ministry of Science and Technology, Chongqing Key Laboratory of Ultrasound in Medicine and Engineering, Chongqing Haifu Hospital, College of Biomedical Engineering, Chongqing Medical University, Chongqing, PR China.
Department of Obstetrics and Gynecology, Chris Hani Baragwanath Academic Hospital, Johannesburg, South Africa.
Eur J Radiol. 2017 Apr;89:117-122. doi: 10.1016/j.ejrad.2017.02.001. Epub 2017 Feb 2.
To investigate the relationship between the features of magnetic resonance imaging (MRI) on T2 weighted images (T2WI) and the therapeutic efficacy of high intensity focused ultrasound (HIFU) on adenomyosis.
From January 2011 to November 2015, four hundred and twenty-eight patients with symptomatic adenomyosis were treated with HIFU. Based on the signal intensity and the number of hyperintense foci in the adenomyotic lesions on T2WI, the patients were classified into groups. The day after HIFU ablation patients underwent contrast-enhanced MRI and a comparison was made of non-perfused volume (NPV) ratio, energy efficiency factor (EEF), treatment time, sonication time, and adverse effects.
No significant difference in terms of HIFU treatment settings and results was observed between the group of patients with hypointense adenomyotic lesions and the group with isointense adenomyotic lesions (P>0.05). However, the sonication time and EEF were significantly higher in the group with multiple hyperintense foci compared to the group with few hyperintense foci. The NPV ratio achieved in the lesions with multiple hyperintenese foci was significantly lower than that in the lesions with few hyperintense foci (P<0.05). No significant difference was observed in the rate of adverse effects between the two groups.
Based on our results, the response of the adenomyotic lesions to HIFU treatment is not related to the signal intensity of adenomyotic lesions on T2WI. However, the number of the high signal intensity foci in the adenomyotic lesions on T2WI can be considered as a predictive factor to help select patients for HIFU treatment.
探讨磁共振成像(MRI)在T2加权像(T2WI)上的特征与高强度聚焦超声(HIFU)治疗子宫腺肌病疗效之间的关系。
2011年1月至2015年11月,428例有症状的子宫腺肌病患者接受了HIFU治疗。根据T2WI上子宫腺肌病病灶的信号强度和高信号灶数量对患者进行分组。HIFU消融术后次日,患者接受对比增强MRI检查,并比较无灌注体积(NPV)比值、能量效率因子(EEF)、治疗时间、超声照射时间和不良反应。
子宫腺肌病病灶呈低信号的患者组与等信号的患者组在HIFU治疗设置和结果方面无显著差异(P>0.05)。然而,与高信号灶较少的组相比,高信号灶较多的组超声照射时间和EEF显著更高。高信号灶较多的病灶的NPV比值显著低于高信号灶较少的病灶(P<0.05)。两组不良反应发生率无显著差异。
根据我们的结果,子宫腺肌病病灶对HIFU治疗的反应与T2WI上子宫腺肌病病灶的信号强度无关。然而,T2WI上子宫腺肌病病灶中高信号强度灶的数量可被视为帮助选择HIFU治疗患者的预测因素。